The studies were conducted in community and residential care settings in Europe and the USA between 1965 and 2000. Older adults receiving the influenza vaccine may experience less influenza over a ...

A cell penetrating format of human single chain antibody (HuScFv) specific to matrix protein (M1) of influenza A virus was produced by molecular linking of the gene sequence encoding the HuScFv ...

“Single-Component Multilayered Self-Assembling Protein Nanoparticles Displaying Extracellular Domains of Matrix Protein 2 as a Pan-influenza A Vaccine” was co-authored by Keegan Braz Gomes, Yi ...

Journal: ACS Nano Published: 2023-11-21 DOI: 10.1021/acsnano.3c06526 Affiliations: 2 Authors: 9 See more details Picked up by 2 news outlets Posted by 13 X users 3 readers on Mendeley Go to article ...

LHNVD-201 is comprised of highly conserved influenza neuraminidase and Matrix (M1/M2) epitopes, and SARS-CoV-2 spike protein and RNA polymerase epitopes.

Matrix protein two (M2) is a transmembrane protein in viral assembly and release. It is a target of antiviral drugs, and certain influenza vaccines contain M2 antigens to elicit immune responses.

For their influenza vaccine, the researchers created an mRNA cocktail encoding the four influenza proteins neuraminidase, nucleoprotein, matrix protein 2, and the stalk portion of hemagglutinin ...

In response, attention has also been directed towards the matrix-2 (M2) protein (Figure 2). This protein spans the membrane of the influenza viral particle and functions to internalize the acid I ...

In coinfected patients, influenza A virus interferes with SARS-CoV-2 replication in the lung and can continue to do so even more than 1 week after clearance of influenza A, according to new research.

Figure 2 Life cycle, humoral immunity targets, and immune escape mechanisms of influenza viruses. The influenza infection starts with (A) the attachment of the viral HA protein to terminal sialic acid ...

Here, we have utilized nucleoside-modified messenger RNA-lipid nanoparticle (mRNA-LNP) vaccines to deliver a combination of influenza virus antigens targeting different conserved proteins to induce ...

The CoVs E protein, similar to the viroporins from the influenza A virus, i.e., matrix protein 2 (M2), and HIV-1, i.e., viral protein U (Vpu), creates an ion channel.